ADAP
Adaptimmune Therapeutics Plc : Guggenheim Cuts Target Price to $3 From $4
时间：2024-11-15 20:40:33 市场： 美股 综合
Adaptimmune - Planning 33% Reduction in Workforce, Believes Restructuring Plan to Result in About $300 Mln in Aggregate Cost Savings Over Next 4 Yrs
时间：2024-11-14 07:04:37 市场： 综合 美股
Adaptimmune Therapeutics Plc: Lete-Cel Achieves Primary Endpoint in Pivotal Trial
时间：2024-11-13 22:13:35 市场： 美股 综合
Adaptimmune Therapeutics Plc - Receives Nasdaq Notice for Non-Compliance With Minimum Bid Price
时间：2024-11-02 05:01:41 市场： 美股 综合
Adaptimmune Therapeutics: Entered Mutual Release and Resolution Agreement With Genentech Inc & F. Hoffmann-La Roche Ltd
时间：2024-09-24 04:43:53 市场： 美股 综合
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Poised to End Week Higher European equities traded in the US as American depositary receipts were moving higher late Friday morning, rising 0.82% to 1,443.36 on the S&P Europe Select ADR Index. The gain is helping the index end the week 1.2% higher.From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and biopharmaceutical firm Genfit (GNFT), which climbed 13% and 4.7%, respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and pharmaceutical firm Ascendis Pharma (ASND), which increased 3.4% and 2.7%, respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and accommodations booking site trivago (TRVG), which fell 2.1% and 1.1%, respectively. They were followed by telecommunications company VEON (VEON) and medical device maker EDAP TMS (EDAP), which were off 0.8% and 0.5%, respectively.From the UK and Irela
时间：2024-09-13 23:19:01 市场： 美股 综合